BLLN BLLN
Company Profile ↓Company Overview
BLLN (BLLN) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 106.2% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $305.11M (+100.0% YoY); net profit $7.45M.
- Trailing 12 Months Year-on-year growth — revenue +100.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 106.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 106.24% |
| 1 Year: | 99.97% |
Stock Price Performance
| 1 Year: | +37.66% |
| 6 Months: | +81.36% |
| 3 Months: | +87.70% |
| 1 Month: | +27.05% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- RSI (14)72.69 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 106.2% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 1071.2.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 38.42M | 58.96M | 83.52M | 108.39M |
| Gross Profit | 20.21M | 37.97M | 58.42M | 79.10M |
| Operating Income | -12.63M | -2.31M | 9.63M | 17.83M |
| Net Income | -14.90M | -3.99M | 5.71M | 17.97M |
| Diluted EPS | -1.47 | -0.39 | 0.10 | 0.34 |
| R&D Expense | 9.55M | 10.43M | 12.95M | 14.69M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 71.73M | 152.58M | 305.11M |
| Gross Profit | 17.31M | 80.92M | 208.46M |
| Operating Income | -69.50M | -47.15M | 16.02M |
| Net Income | -82.68M | -41.57M | 7.45M |
| Diluted EPS | -8.45 | -4.12 | 0.14 |
| R&D Expense | 22.41M | 36.60M | 49.38M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | - | - | 302.06M | 632.65M |
| Total Equity | -141.81M | -219.05M | -251.66M | 480.11M |
| Cash & Equivalents | - | - | 191.48M | 495.98M |
| Long Term Debt | - | - | 51.48M | 57.23M |
| Total Liabilities | - | - | 134.31M | 152.55M |
| Current Liabilities | - | - | 28.39M | 47.96M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | -53.67M | -41.38M | 24.59M |
| Investing Cash Flow | 82.84M | -5.43M | -8.92M |
| Financing Cash Flow | 13.40M | 141.02M | 288.82M |
| Capital Expenditure | -6.17M | -5.40M | -8.88M |
| Free Cash Flow | -59.85M | -46.78M | 15.71M |
| Share Buybacks | 0 | 546.00K | 0 |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | 24.1% | 53.0% | 68.3% |
| Operating Margin % | -96.9% | -30.9% | 5.3% |
| Net Margin % | -115.3% | -27.2% | 2.4% |
| ROE % | 37.7% | 16.5% | 1.6% |
| ROCE % | - | -17.2% | 2.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BLLN
BillionToOne (BLLN) Releases Q2 2026 Earnings: Revenue Growth but EPS Profit - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQZkxFczVlLVY3aWxvemhxME9Nak1iVWt3bmcwMlBrazQwUnZXdGRnUnZkQUJNQVY0T0lRaEk0amlMbjRPZ2FMc01LdHhRQzZDSjNQbnlEMVZra2kxaXJucnlvbkp1aER2SzRVXzBBMHlqT0tqS0hKVlZNTDRmLVhIVTdQbFdEelNsMmdSbH…
BLLN (NASDAQ: BLLN) holders plan sale of 15,539 Class A shares - Stock Titan
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxOS1E0WnR0MDdWREJQa0RHdktqZ1dwam5aVG1WdHJGcXFsejl2bmdxMUxYWkNJVlUyVVBBVWR6LUhLSTJTVGQ4cUs2SlUtbUpmSU9Lb2VWSzhISllVSDZaVTZnU1VFaUpsM0p3UG9RdXhDWl9BVjJrUERwVkdpRGl2SnpPT1pmWkRJbjdDa0…
Billiontoone (NASDAQ:BLLN) Sets New 1-Year High - Should You Buy? - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOUFdlR3NWcUI3TDZQTzJwQkw4WHl3eWVUT0lnMTh4RG9RQWo5N2JJMTc0dkx0TzNMbXhTZGVEYmhtaGcyT2RzeXVUMm41RnlxekFUSk50VXcyYmQ0NHdpaGFGNGtlRmtoUnA2RFVqWGNmTW9aSFo1end4bktQSDMyaWpMVzlJanl5WE5JRF…
Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOcTJqY3F6T25SUUV3NE1ydy1rNXFHdW5ZR2RXNTI1UlNHdDl4OXpwLUZIVlU0T3Vhd3JpLXFsMi1rLTg3OFRhTWhrOHgzenlmeURONHBFTmVZUkNjRzhoQUtacXI4NkFvN2xPRUFHZkxQVk1IZWZ5bUcxTUdfMlBrck9lY0g4eEhQSkZRan…
Earnings Flash (BLLN) BillionToOne, Inc. Reports Q2 Revenue $109.4M, vs. FactSet Est of $109.2M - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxQdVVDQnRvbXJyOG1hTjRCcDhCNlI3UnQ0ZkFJZHZiSDRGTTY4cEJoQ0RyR3E0VjVCWkpjcnliYjFTekxYSDIzaFBPeXZQYVp1UndELW8tWnRFWmstbXUxRnBEVkIyN0RpMVZ6bFJRM0ZPWFU3SnFwTjlBSUtuU1FZbzY4Zi1UWENkZ1RCR1…
BillionToOne Inc (BLLN) Q2 2026 Earnings Report Preview: What To Expect - GuruFocus
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPUDluR3d4cF95Y1FlQnJPY1VOSDQxYm5MZ2VYdWlGRklnQkh2ajFxT3RhNVBqQzZZbFJBUGxtSGZiT2psLXp2VER4VXJQZGp4OE1NXy1UWEV5S1UzTHNJUS1KUHdvN082N3dCOUl0RWY3dG1TUmxiTTQzV1huVGpZbjVaR1JOVHVSWmdIUX…
BLLN — Frequently Asked Questions
What is the current share price of BLLN?
As of 2026-08-05 17:25 PDT, BLLN trades at $149.97 on NASDAQ/NYSE. Its 52-week range is $64.03 to $149.97.
What is the P/E ratio of BLLN?
BLLN trades at a trailing price-to-earnings (P/E) ratio of 1,071.21.
What is the return on equity (ROE) of BLLN?
BLLN has a return on equity (ROE) of 1.55%. Its return on capital employed (ROCE) is 2.74%.
Is BLLN a good stock to buy?
This page provides a data-driven analysis of BLLN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.